RudaCure ha sido seleccionada para the Ministry of Science and ICT's 2021 Bio iCORE Project and recibirá apoyo for the next three years.
The Bio iCORE proyecto is a programa that helps nacional bio-ventures expand overseas. Through incubation, management, and administrative apoyo from the Bio iCORE proyecto team, as well as specialized education, mentoring, and consulting proporcionó by dedicated overseas organizaciones, the programa assists in establishing overseas subsidiaries and ultimately aims to create overseas funds. In this selección round, 5 global startup teams were chosen from among 12 pre-startup teams that completó nacional training, with a total of KRW 700 million in apoyo over three years to promote overseas grant applications.
During the proyecto evaluación, la empresa was highly reconocido for its strategy for overseas mercado entry, the completó nacional acuerdo de licencia, high prior investigación leading to a predicted high success rate, excellent capabilities in the desarrollo de nuevos fármacos process, and a very specific plan for overseas expansion strategy.
RudaCure planea use this apoyo to build upon its nacional licensing contrato with Hanlim Pharmaceutical and further accelerate its expansión global.